Back

The soluble IL6 receptor and ischemic cerebrovascular disease

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Peripheral vascular and cerebrovascular disease: pathophysiology Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Louise Ziegler

Karolinska Institute, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose lowering therapy
Mr A. Mahdi (Stockholm, SE)
Abstract
Presentation thumbnail
The associations between the effect of cilostazol on the proprotein convertase subtilisin/kexin type 9 concentrations and circulating endothelial progenitor cells and vasculo-angiogenesis factors
Professor T. Chao (Taichung, TW)
Abstract
Presentation thumbnail
Improvement of endothelial glycocalyx thickness after anti-inflammatory treatment is related with reduced arterial blood pressure, stiffness and wave reflections in psoriasis.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Ageing-related endothelial dysfunction in the femoral vein is mediated by cyclooxygenases: Role of thromboxane prostanoid receptors
Doctor S. Gaertner (Strasbourg, FR)
Abstract
Presentation thumbnail
Transferrin receptor 1 hetero deletion attenuates angiogenesis in mouse hind limb ischemia model
Doctor K. Okuno (Philadelphia, US)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Peripheral vascular and cerebrovascular disease: pathophysiology

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources